Taysha Gene Therapies, Inc.

Siren, L.L.C. TSHA
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/14/2026
Shares
8,829,913
Value ($000)
39,470
Weight
1.1%
2024 Q3 - 2026 Q1 (7 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).